The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 1, 1997, Pages 5-12

  Erah, P O ^a   Goddard, A F ^b   Barrett, D A ^a   Shaw, P N ^a   Spiller, R C ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANTIMICROBIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG STABILITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; STOMACH JUICE; STOMACH PH;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; GASTRIC JUICE; HALF-LIFE; HELICOBACTER; HELICOBACTER INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; METRONIDAZOLE; OMEPRAZOLE; PENICILLINS; SOLUTIONS;

EID: 0031048495     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.1.5     Document Type: Article

References (28)

1. Ateshkadi, A., Lam, N. P. & Johnson, C. A. (1993). Helicobacter pylori and peptic ulcer disease. Clinical Pharmacy 12, 34-48.
2. Axon, A. T. R. (1991). Helicobacter pylori therapy: effect on peptic ulcer disease. Journal of Gastroenterology and Hepatology 6, 131-7.
3. Mégraud, F., Brassens-Rabbe, M. P., Denis, F., Belbouri, A. & Hoa, D. Q. (1989). Seroepidemiology of Campylobacter pylori infection in various populations. Journal of Clinical Microbiology 27, 1870-3.
4. Holcombe, C., Omotara, B. A., Eldridge, J. & Jones, D. M. (1992). H. pylori, the most common bacterial infection in Africa: a random serological study. American Journal of Gastroenterology 87, 28-30.
5. Hentschel, E., Brandstatter, G., Dragosics, B., Hirschl, A. M., Nemec, H., Shutze, K. et al. (1993). Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New England Journal of Medicine 328, 308-12.
6. Goddard, A. F. & Spiller, R. C. (1996). The effect of omeprazole on gastric juice viscocity, pH and bacterial counts. Alimentary Pharmacology and Therapeutics 10, 105-9.
7. Peterson, W. L. (1991). Helicobacter pylori and peptic ulcer disease. New England Journal of Medicine 324, 1043-8.
8. McNulty, C. A. M., Dent, J. C., Ford, G. A. & Wilkinson, S. P. (1988). Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. Journal of Antimicrobial Chemotherapy 22, 729-38.
9. Mégraud, F., Trimoulet, P., Lamouliatte, H. & Boyanova, L. (1991). Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrobial Agents and Chemotherapy 35, 869-72.
10. Darmaillac, V., Bouchard, S., Lamouliatte, H. & Mégraud, F. (1995). Macrolides and Helicobacter pylori. Determination of MICs and effect of pH. Gastroenterology 108, Suppl., A78.
11. Logan, R. P. H., Gummett, P. A., Schaufelberger, H. D., Greaves, R. R. F. H., Mendelson, G. M., Walker, M. M. et al. (1994). Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 35, 323-6.
12. Lind, T., Veldhuyzen van Zanten, S. J. O., Unge, P., Spiller, R. C., Bayedörrffer, E., O'Morain, C. et al. (1996). Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH study. Helicobacter 1, 138-44.
13. Clissold, S. P. & Campoli-Richards, D. M. (1986). Omeprazole: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32, 15-47.
14. Atherton, J. C., Cockayne, A., Balsitis, M., Kirk, G. E., Hawkey, C. J. & Spiller, R. C. (1995). Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut 36, 670-4.
15. Wang, D. & Yeh, M. (1993). Degradation kinetics of metronidazole in solution. Journal of Pharmaceutical Sciences 82, 95-8.
16. Erah, P. O., Goddard, A. F., Barren, D. A., Shaw, P. N. & Spiller, R. C. (1995). Effect of pH on the stability of amoxycillin in buffered aqueous solutions and in gastric juice. Pharmaceutical Sciences 1, 597-600.
17. Nakagawa, Y., Itai, S., Yoshida, T. & Nagai, T. (1992). Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chemical and Pharmaceutical Bulletin 40, 725-8.
18. Tsuji, A., Nakashima, E., Hamano, S. & Yamana, T. (1978). Physicochemical properties of amphoteric β-lactam antibiotics I: stability, solubility, and dissolution behavior of amino penicillins as a function of pH. Journal of Pharmaceutical Sciences 67, 1059-66.
19. Erah, P. O., Barrett, D. A. & Shaw, P. N. (1996). Ion-pair high performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. Journal of Chromatography B 682, 73-8.
20. Jessa, M. J., Barrett, D. A., Shaw, P. N. & Spiller, R. C. (1996). A rapid and selective high performance liquid chromatography method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. Journal of Chromatography B 677, 374-9.
21. De Pourcq, P., Hoebus, J., Roets, E., Hoogmartens, J. & Vanderhaeghe, H. (1985). Quantitative determination of amoxicillin and its decomposition products by high-performance liquid chromatography. Journal of Chromatography 321, 441-9.
22. Verdu, E., Viani, F., Amstrong, D., Fraser, R., Siegrist, H. H., Pignatelli, B. et al. (1994). Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 35, 455-60.
23. Adamek, R. J., Freitag, M., Opferkuch, W., Ruhl, G. H. & Wegener, M. (1994). Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-posttive acute peptic ulcer bleeding. A pilot-study. Scandinavian Journal of Gastroenterology 29, 880-3.
24. Sung, J. J. Y., Chung, S. C. S., Hosking, S. W., Chan, R. C. Y., Ling, T. K. W., Yung, M. Y. et al. (1995). Mucosal pharmacokinetics and pilot study of short course of parenteral imipenem in the eradication of Helicobacter pylori. Journal of Gastroenterology and Hepatology 10, 66-9.
25. Goddard, A. F., Jessa, M. J., Barrett, D. A., Shaw, P. N., Idström, J. P., Cederberg, C. et al. (1995). Effect of omeprazole on the distribution of metronidazole, amoxycillin, and clarithromycin in human gastric juice. Gastroenterology 111, 358-67.
26. Lund, W. (Ed.) (1994). The Pharmaceutical Codex. Principles and Practice of Pharmaceutics, 12th edn. Pharmaceutical Press, London.
27. Goddard, A. F. & Logan, R. P. H. (1996). Antimicrobial resistance and Helicobacter pylori. Journal of Antimicrobial Chemotherapy 37, 639-43.
28. +) ATPase protein and increases permeability of oxyntic secretory membranes in rabbits. American Journal of Physiology 265, G231-41.